These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 20233909)

  • 1. Diabetes mellitus, inflammation, obesity: proposed treatment pathways for current and future therapies.
    Sonnett TE; Levien TL; Gates BJ; Robinson JD; Campbell RK
    Ann Pharmacother; 2010 Apr; 44(4):701-11. PubMed ID: 20233909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of metformin for weight management in patients without type 2 diabetes.
    Desilets AR; Dhakal-Karki S; Dunican KC
    Ann Pharmacother; 2008 Jun; 42(6):817-26. PubMed ID: 18477733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rationale for dipeptidyl peptidase 4 inhibitors: a new class of oral agents for the treatment of type 2 diabetes mellitus.
    Campbell RK
    Ann Pharmacother; 2007 Jan; 41(1):51-60. PubMed ID: 17190843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacotherapeutic options for overweight adolescents.
    Dunican KC; Desilets AR; Montalbano JK
    Ann Pharmacother; 2007 Sep; 41(9):1445-55. PubMed ID: 17652127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of various treatments on leptin, adiponectin, ghrelin and neuropeptide Y in patients with type 2 diabetes mellitus.
    Katsiki N; Mikhailidis DP; Gotzamani-Psarrakou A; Yovos JG; Karamitsos D
    Expert Opin Ther Targets; 2011 Apr; 15(4):401-20. PubMed ID: 21261565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of beta 3-adrenoceptor agonists for the treatment of obesity and diabetes--an update.
    Weyer C; Gautier JF; Danforth E
    Diabetes Metab; 1999 Mar; 25(1):11-21. PubMed ID: 10335419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Teplizumab for treatment of type 1 diabetes mellitus.
    Skelley JW; Elmore LK; Kyle JA
    Ann Pharmacother; 2012 Oct; 46(10):1405-12. PubMed ID: 22968521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel factors as therapeutic targets to treat diabetes. Focus on leptin and ghrelin.
    Gómez R; Lago F; Gómez-Reino JJ; Gualillo O
    Expert Opin Ther Targets; 2009 May; 13(5):583-91. PubMed ID: 19397477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural compound renews hope for diabetes and obesity therapeutic target.
    Merk D; Schubert-Zsilavecz M
    Future Med Chem; 2015; 7(7):833-5. PubMed ID: 26061101
    [No Abstract]   [Full Text] [Related]  

  • 10. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.
    Kang JH; Goto T; Han IS; Kawada T; Kim YM; Yu R
    Obesity (Silver Spring); 2010 Apr; 18(4):780-7. PubMed ID: 19798065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential therapies based on antidiabetic peptides.
    Billyard T; McTernan P; Kumar S
    Best Pract Res Clin Endocrinol Metab; 2007 Dec; 21(4):641-55. PubMed ID: 18054740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical therapy for the patient with obesity.
    Bray GA; Ryan DH
    Circulation; 2012 Apr; 125(13):1695-703. PubMed ID: 22474312
    [No Abstract]   [Full Text] [Related]  

  • 13. Leptin, adiponectin, resistin, and ghrelin--implications for inflammatory bowel disease.
    Karmiris K; Koutroubakis IE; Kouroumalis EA
    Mol Nutr Food Res; 2008 Aug; 52(8):855-66. PubMed ID: 18383234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pomegranate as a Possible Treatment in Reducing Risk of Developing Wound Healing, Obesity, Neurodegenerative Disorders, and Diabetes Mellitus.
    AlMatar M; Islam MR; Albarri O; Var I; Koksal F
    Mini Rev Med Chem; 2018; 18(6):507-526. PubMed ID: 28425868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current and investigational antiobesity agents and obesity therapeutic treatment targets.
    Bays HE
    Obes Res; 2004 Aug; 12(8):1197-211. PubMed ID: 15340100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffusion into use of exenatide for glucose control in diabetes mellitus: a retrospective cohort study of a new therapy.
    Segal JB; Dy SM; Millman EA; Herbert R; Bass EB; Wu A
    Clin Ther; 2007 Aug; 29(8):1784-94. PubMed ID: 17919559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amylin improves the effect of leptin on insulin sensitivity in leptin-resistant diet-induced obese mice.
    Kusakabe T; Ebihara K; Sakai T; Miyamoto L; Aotani D; Yamamoto Y; Yamamoto-Kataoka S; Aizawa-Abe M; Fujikura J; Hosoda K; Nakao K
    Am J Physiol Endocrinol Metab; 2012 Apr; 302(8):E924-31. PubMed ID: 22275759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of colesevelam hydrochloride in hypercholesterolemia and type 2 diabetes mellitus.
    Brunetti L; Hermes-Desantis ER
    Ann Pharmacother; 2010; 44(7-8):1196-206. PubMed ID: 20551301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in the pathophysiology and pharmacological treatment of obesity.
    Chugh PK; Sharma S
    J Clin Pharm Ther; 2012 Oct; 37(5):525-35. PubMed ID: 22462645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exenatide. Amylin/Eli Lilly.
    Giannoukakis N
    Curr Opin Investig Drugs; 2003 Apr; 4(4):459-65. PubMed ID: 12808888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.